中国化学(601117) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 44,939,439,685.36, representing a year-on-year increase of 5.51%[4] - The net profit attributable to shareholders for Q1 2024 was CNY 1,216,457,284.75, reflecting a growth of 9.50% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 1,151,284,672.99, an increase of 3.70% year-on-year[4] - The basic earnings per share for Q1 2024 was CNY 0.20, up by 11.11% from the previous year[4] - Total operating revenue for Q1 2024 reached ¥45.17 billion, a 5.5% increase from ¥42.80 billion in Q1 2023[21] - Net profit for Q1 2024 was ¥1.35 billion, up 16.8% from ¥1.16 billion in Q1 2023[22] - Operating profit for Q1 2024 was ¥1.60 billion, an increase of 19.4% compared to ¥1.34 billion in Q1 2023[22] - Total comprehensive income for Q1 2024 was ¥1.35 billion, compared to ¥1.15 billion in Q1 2023, reflecting a growth of 16.9%[24] Assets and Liabilities - The total assets at the end of Q1 2024 amounted to CNY 219,707,466,695.65, a slight increase of 0.27% from the end of the previous year[5] - The total liabilities as of March 31, 2024, were CNY 153.922 billion, a decrease from CNY 155.043 billion at the end of 2023[19] - The total equity attributable to shareholders as of March 31, 2024, was CNY 58.770 billion, up from CNY 57.495 billion at the end of 2023[19] - As of March 31, 2024, the total current assets amounted to CNY 170.099 billion, slightly up from CNY 169.386 billion at the end of 2023[17] Cash Flow - The net cash flow from operating activities for Q1 2024 was negative at CNY -6,770,097,872.17, indicating a significant cash outflow[4] - Cash flow from operating activities showed a net outflow of ¥6.77 billion in Q1 2024, compared to a net outflow of ¥6.02 billion in Q1 2023[25] - The company reported a cash and cash equivalents balance of CNY 40.009 billion as of March 31, 2024, down from CNY 48.639 billion at the end of 2023[17] - The total cash and cash equivalents at the end of Q1 2024 were $35,594,343,825.25, compared to$31,408,728,097.33 at the end of Q1 2023, reflecting a year-over-year increase[26] - The cash and cash equivalents decreased by $7,610,032,500.62 in Q1 2024, compared to a decrease of$4,676,161,356.32 in Q1 2023[26] Shareholder Information - The top shareholder, China Chemical Engineering Group Co., Ltd., holds 40.24% of the shares, amounting to 2,458,550,228 shares[9] Investment and Financing Activities - The new contract amount signed in Q1 2024 reached CNY 127.916 billion, up 22.29% year-on-year, with domestic contracts accounting for CNY 105.357 billion and overseas contracts CNY 22.559 billion[14] - The company received $136,345,000.00 from minority shareholders in Q1 2024, a significant increase from$17,453,912.50 in Q1 2023[26] - Cash outflow for debt repayment was $1,925,726,209.00, compared to$398,943,539.27 in Q1 2023, indicating increased debt servicing[26] - The net cash flow from financing activities showed a decline of $3,321,014,503.06, moving from a positive$2,073,922,649.68 in Q1 2023 to a negative $1,248,091,853.38 in Q1 2024[26] Research and Development - Research and development expenses decreased to ¥959.46 million in Q1 2024 from ¥1.01 billion in Q1 2023, a reduction of 4.6%[21] Market Strategy - The company has not disclosed any significant new product developments or market expansion strategies in this report[12] - The company plans to continue focusing on high-quality development and expanding its market presence in the industrial engineering sector[14]